A detailed history of Allspring Global Investments Holdings, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 538,493 shares of BMY stock, worth $26.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
538,493
Previous 1,507,928 64.29%
Holding current value
$26.2 Million
Previous $81.8 Million 72.65%
% of portfolio
0.04%
Previous 0.13%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$40.25 - $52.99 $39 Million - $51.4 Million
-969,435 Reduced 64.29%
538,493 $22.4 Million
Q1 2024

Apr 18, 2024

SELL
$47.98 - $54.4 $11.1 Million - $12.6 Million
-232,225 Reduced 13.35%
1,507,928 $81.8 Million
Q4 2023

Jan 25, 2024

BUY
$48.48 - $57.85 $8.6 Million - $10.3 Million
177,387 Added 11.35%
1,740,153 $89.3 Million
Q3 2023

Oct 27, 2023

BUY
$57.89 - $64.73 $90.5 Million - $101 Million
1,562,766 New
1,562,766 $90.7 Million
Q2 2023

Jul 18, 2023

SELL
$63.71 - $70.74 $2.2 Million - $2.45 Million
-34,571 Reduced 1.94%
1,750,972 $112 Million
Q1 2023

Apr 13, 2023

BUY
$65.71 - $74.53 $15.3 Million - $17.4 Million
232,944 Added 15.0%
1,785,543 $124 Million
Q4 2022

Jan 23, 2023

BUY
$68.48 - $81.09 $5.05 Million - $5.98 Million
73,768 Added 4.99%
1,552,599 $0
Q3 2022

Oct 26, 2022

BUY
$0.13 - $76.84 $38,209 - $22.6 Million
293,920 Added 24.81%
1,478,831 $105 Million
Q2 2022

Jul 25, 2022

SELL
$72.62 - $79.98 $32.8 Million - $36.1 Million
-451,529 Reduced 27.59%
1,184,911 $91.2 Million
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $48.1 Million - $57.7 Million
-783,107 Reduced 32.37%
1,636,440 $120 Million
Q4 2021

Jan 28, 2022

BUY
$53.63 - $62.52 $130 Million - $151 Million
2,419,547 New
2,419,547 $151 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.